🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy

Recruitingn/aAges 18 Years - anyAllFederico II University
NCT06287177 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients under Inclisiran treatment Exclusion Criteria: * Age \< 18 years o \> 80 years * Patients who refuse to participate and to sign informed consent
💊

What it tests

  • Inclisiran
📍

Where

1 site
Federico II University of Naples, Department of Advanced Biomedical Sciences
Naples, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy